Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)
China
· Delayed Price · Currency is CNY 14.12
+0.17 (1.22%)
At close: Apr 30, 2025
SHE:002907 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 76.73 | 76.73 | 32.7 | 98.4 | 91.78 | 119.19 | Upgrade
|
| Depreciation & Amortization | 85.11 | 85.11 | 82.11 | 74.69 | 69.84 | 46.89 | Upgrade
|
| Other Amortization | 4.28 | 4.28 | 1.28 | 1.1 | 0.57 | 0.43 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0.06 | - | - | -0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 3.53 | 3.53 | 1.87 | 4.77 | 0.15 | -0.3 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.38 | -1.38 | 4.67 | 2.61 | 1.33 | -5.45 | Upgrade
|
| Other Operating Activities | 9.69 | -3.31 | 0.95 | 14.42 | 18.22 | 17.21 | Upgrade
|
| Change in Accounts Receivable | -30.3 | -30.3 | 84.86 | -85.87 | -16.39 | 68.32 | Upgrade
|
| Change in Inventory | 10.59 | 10.59 | -38.02 | 11.42 | -8.71 | -32.35 | Upgrade
|
| Change in Accounts Payable | 17.28 | 17.28 | 45.63 | -106.82 | -75.39 | -93.51 | Upgrade
|
| Operating Cash Flow | 174.77 | 161.77 | 219.34 | 13.04 | 82.85 | 113.64 | Upgrade
|
| Operating Cash Flow Growth | 35.66% | -26.25% | 1581.42% | -84.25% | -27.09% | 72.40% | Upgrade
|
| Capital Expenditures | -14.95 | -16.15 | -92.82 | -60.62 | -56.64 | -46.69 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 0 | - | - | - | 0 | Upgrade
|
| Divestitures | - | - | - | - | 0 | - | Upgrade
|
| Investment in Securities | -274.94 | -94.94 | -65.01 | 52.04 | -53 | 126.5 | Upgrade
|
| Other Investing Activities | 5.08 | 3.87 | 0.49 | 3.29 | 1.1 | 7.52 | Upgrade
|
| Investing Cash Flow | -284.8 | -107.21 | -157.34 | -5.29 | -108.54 | 87.33 | Upgrade
|
| Short-Term Debt Issued | - | - | 70 | - | - | 12 | Upgrade
|
| Long-Term Debt Issued | - | - | 0.2 | - | - | - | Upgrade
|
| Total Debt Issued | - | - | 70.2 | - | - | 12 | Upgrade
|
| Short-Term Debt Repaid | - | - | -70 | - | -12 | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.14 | -0.26 | -2.19 | -0.03 | - | Upgrade
|
| Total Debt Repaid | -0.14 | -0.14 | -70.26 | -2.19 | -12.03 | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.14 | -0.14 | -0.06 | -2.19 | -12.03 | 12 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 1.7 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -7.11 | -0.23 | -0.41 | Upgrade
|
| Common Dividends Paid | -35.5 | -35.5 | -30.17 | -23.04 | -13.4 | -19.38 | Upgrade
|
| Other Financing Activities | 0.07 | - | - | - | - | - | Upgrade
|
| Financing Cash Flow | -35.56 | -35.63 | -30.23 | -32.35 | -25.66 | -6.09 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.08 | 0.06 | 0.07 | 0.35 | -0.09 | -0.27 | Upgrade
|
| Net Cash Flow | -145.67 | 18.99 | 31.84 | -24.24 | -51.44 | 194.61 | Upgrade
|
| Free Cash Flow | 159.82 | 145.62 | 126.52 | -47.57 | 26.21 | 66.95 | Upgrade
|
| Free Cash Flow Growth | 251.63% | 15.09% | - | - | -60.85% | 5242.87% | Upgrade
|
| Free Cash Flow Margin | 20.35% | 18.79% | 18.30% | -6.06% | 3.10% | 7.59% | Upgrade
|
| Free Cash Flow Per Share | 0.38 | - | 0.30 | -0.12 | 0.07 | 0.17 | Upgrade
|
| Cash Income Tax Paid | 81.71 | 80.82 | 80.76 | 60.68 | 89.24 | 92.05 | Upgrade
|
| Levered Free Cash Flow | 100.53 | 118.87 | 32.03 | 1.63 | -2.62 | 36.71 | Upgrade
|
| Unlevered Free Cash Flow | 100.53 | 118.87 | 32.62 | 10.64 | 8.77 | 47.47 | Upgrade
|
| Change in Net Working Capital | 12.47 | -6.66 | -23.67 | 65.53 | 62.94 | 25.4 | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.